BNP Paribas Financial Markets Has $6.25 Million Stake in Henry Schein, Inc. (NASDAQ:HSIC)

BNP Paribas Financial Markets increased its stake in shares of Henry Schein, Inc. (NASDAQ:HSICFree Report) by 36.0% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 82,517 shares of the company’s stock after buying an additional 21,838 shares during the quarter. BNP Paribas Financial Markets owned about 0.06% of Henry Schein worth $6,247,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently added to or reduced their stakes in the stock. Everett Harris & Co. CA increased its position in shares of Henry Schein by 29.1% in the fourth quarter. Everett Harris & Co. CA now owns 104,677 shares of the company’s stock worth $7,925,000 after purchasing an additional 23,622 shares during the period. Duality Advisers LP acquired a new position in shares of Henry Schein in the 4th quarter valued at approximately $1,561,000. Sprucegrove Investment Management Ltd. lifted its holdings in shares of Henry Schein by 14.2% during the 4th quarter. Sprucegrove Investment Management Ltd. now owns 220,491 shares of the company’s stock worth $16,693,000 after acquiring an additional 27,500 shares during the period. Victory Capital Management Inc. boosted its position in shares of Henry Schein by 10.9% during the 4th quarter. Victory Capital Management Inc. now owns 151,657 shares of the company’s stock worth $11,482,000 after acquiring an additional 14,868 shares in the last quarter. Finally, International Assets Investment Management LLC bought a new position in Henry Schein in the fourth quarter valued at approximately $3,754,000. Institutional investors own 96.62% of the company’s stock.

Analyst Ratings Changes

A number of equities research analysts have weighed in on HSIC shares. TheStreet raised Henry Schein from a “c+” rating to a “b-” rating in a report on Monday, February 26th. JPMorgan Chase & Co. increased their target price on shares of Henry Schein from $82.00 to $88.00 and gave the stock an “overweight” rating in a report on Wednesday, March 6th. Barrington Research lifted their price target on shares of Henry Schein from $90.00 to $92.00 and gave the company an “outperform” rating in a report on Wednesday, May 8th. Piper Sandler increased their price objective on shares of Henry Schein from $78.00 to $86.00 and gave the company an “overweight” rating in a research note on Monday, February 26th. Finally, Jefferies Financial Group boosted their target price on shares of Henry Schein from $74.00 to $81.00 and gave the stock a “hold” rating in a research note on Wednesday, March 6th. One research analyst has rated the stock with a sell rating, six have issued a hold rating and five have assigned a buy rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of “Hold” and an average price target of $81.73.

Check Out Our Latest Stock Analysis on HSIC

Henry Schein Price Performance

Shares of HSIC opened at $74.60 on Friday. The business has a 50-day moving average of $72.72 and a 200-day moving average of $72.69. The company has a debt-to-equity ratio of 0.47, a current ratio of 1.75 and a quick ratio of 1.02. The company has a market capitalization of $9.55 billion, a price-to-earnings ratio of 25.20, a price-to-earnings-growth ratio of 1.94 and a beta of 0.87. Henry Schein, Inc. has a 1 year low of $60.01 and a 1 year high of $82.63.

Henry Schein (NASDAQ:HSICGet Free Report) last released its quarterly earnings results on Tuesday, May 7th. The company reported $1.10 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.01 by $0.09. Henry Schein had a net margin of 3.12% and a return on equity of 13.51%. The firm had revenue of $3.17 billion during the quarter, compared to analyst estimates of $3.21 billion. During the same quarter last year, the business earned $1.21 EPS. The company’s revenue was up 3.7% compared to the same quarter last year. As a group, equities research analysts anticipate that Henry Schein, Inc. will post 5.08 earnings per share for the current year.

Insiders Place Their Bets

In other news, CEO Bradford C. Connett sold 6,430 shares of the business’s stock in a transaction dated Wednesday, March 20th. The stock was sold at an average price of $74.28, for a total value of $477,620.40. Following the transaction, the chief executive officer now directly owns 73,108 shares of the company’s stock, valued at approximately $5,430,462.24. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. In other Henry Schein news, CEO Bradford C. Connett sold 6,430 shares of Henry Schein stock in a transaction that occurred on Wednesday, March 20th. The stock was sold at an average price of $74.28, for a total value of $477,620.40. Following the completion of the sale, the chief executive officer now directly owns 73,108 shares in the company, valued at $5,430,462.24. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, Vice Chairman James P. Breslawski sold 2,907 shares of the stock in a transaction that occurred on Monday, March 18th. The stock was sold at an average price of $74.37, for a total value of $216,193.59. Following the transaction, the insider now owns 209,562 shares in the company, valued at $15,585,125.94. The disclosure for this sale can be found here. Company insiders own 1.14% of the company’s stock.

Henry Schein Profile

(Free Report)

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.

See Also

Want to see what other hedge funds are holding HSIC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Henry Schein, Inc. (NASDAQ:HSICFree Report).

Institutional Ownership by Quarter for Henry Schein (NASDAQ:HSIC)

Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.